1. Home
  2. DYN vs CDE Comparison

DYN vs CDE Comparison

Compare DYN & CDE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DYN
  • CDE
  • Stock Information
  • Founded
  • DYN 1984
  • CDE 1928
  • Country
  • DYN United States
  • CDE United States
  • Employees
  • DYN N/A
  • CDE N/A
  • Industry
  • DYN Medicinal Chemicals and Botanical Products
  • CDE Precious Metals
  • Sector
  • DYN Health Care
  • CDE Basic Materials
  • Exchange
  • DYN Nasdaq
  • CDE Nasdaq
  • Market Cap
  • DYN 2.6B
  • CDE 2.5B
  • IPO Year
  • DYN 2020
  • CDE N/A
  • Fundamental
  • Price
  • DYN $14.13
  • CDE $6.17
  • Analyst Decision
  • DYN Strong Buy
  • CDE Strong Buy
  • Analyst Count
  • DYN 10
  • CDE 4
  • Target Price
  • DYN $50.70
  • CDE $7.81
  • AVG Volume (30 Days)
  • DYN 1.8M
  • CDE 9.8M
  • Earning Date
  • DYN 03-04-2025
  • CDE 02-19-2025
  • Dividend Yield
  • DYN N/A
  • CDE N/A
  • EPS Growth
  • DYN N/A
  • CDE N/A
  • EPS
  • DYN N/A
  • CDE N/A
  • Revenue
  • DYN N/A
  • CDE $1,010,652,000.00
  • Revenue This Year
  • DYN N/A
  • CDE $32.61
  • Revenue Next Year
  • DYN N/A
  • CDE $39.85
  • P/E Ratio
  • DYN N/A
  • CDE N/A
  • Revenue Growth
  • DYN N/A
  • CDE 31.38
  • 52 Week Low
  • DYN $14.03
  • CDE $2.42
  • 52 Week High
  • DYN $47.45
  • CDE $7.72
  • Technical
  • Relative Strength Index (RSI)
  • DYN 19.54
  • CDE 49.13
  • Support Level
  • DYN $14.79
  • CDE $5.90
  • Resistance Level
  • DYN $15.90
  • CDE $6.60
  • Average True Range (ATR)
  • DYN 1.55
  • CDE 0.30
  • MACD
  • DYN -0.82
  • CDE 0.04
  • Stochastic Oscillator
  • DYN 0.82
  • CDE 56.64

About DYN Dyne Therapeutics Inc.

Dyne Therapeutics Inc is a biotechnology company focused on providing therapeutics for patients with genetically driven diseases. The company overcomes the limitations of muscle tissue delivery and modern oligonucleotide therapeutics for muscle diseases. The company is developing therapies for muscle disorders like Myotonic dystrophy, Duchenne muscular dystrophy, and Facioscapulohumeral muscular dystrophy. The company's product candidates are DYNE-101 and DYNE-251, both are in the ongoing phase 1/2 clinical trial.

About CDE Coeur Mining Inc.

Coeur Mining Inc is a metals producer focused on mining precious minerals in the Americas. It is involved in the discovery and mining of gold and silver and generates the vast majority of revenue from the sale of these precious metals. The operating mines of the company are palmarejo, Rochester, Wharf, and Kensington. Its projects are located in the United States, Canada Mexico, and North America.

Share on Social Networks: